CTSO CytoSorbents Corporation: Margin operasi

Lambang korporat lan logo CytoSorbents Corp (CTSO)

Cytosorbents minimizes risks by developing blood purification systems for intensive care units. The current operating margin illustrates this efficiency, where -26.70 characterizes this valuation parameter. Profit stability is based on a global distribution network across Europe and the US. The defensive qualities of the business and demographic factors insulate financial results from market downturns.

CTSO: Margin operasi CytoSorbents Corp. 04.07.2022 - 19.11.2026

CytoSorbents Corp - rincian analitis lan metrik utama (CTSO)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:CTSO, CytoSorbents Corporation
Produk merek CytoSorbents Corporation

The effective commercialization of blood filtration systems in the US and EU directly correlates with the operating profit spread, calculated as the ratio of operating profit to revenue. This chart allows for an assessment of Cytosorbents (CTSO) management's ability to transform revenues into net operating cash flow before financial obligations, confirming the stability of the market capitalization through the fundamental efficiency of the business model.

Pesaing Cytosorbents (CTSO)

DXCM (Dexcom CGM) - Margin operasi|Margin dodolan operasi Penumbra Corp (PEN)|Margin operasi NOVT|Margin operasi haemonetics.com (HAE)|Margin operasi INSP (inspiresleep.com)|Margin operasi PROCEPT BioRobotics Corp PRCT|CNMD - Rentabilitas operasi|PLSE: Rentabilitas operasi|INMD (InMode Ltd.) - Margin dodolan operasi|Rentabilitas dodolan operasi picardmedical.com (PMI)|SRDX (Surmodics Inc.) - Margin operasi|Rentabilitas dodolan operasi Senseonics SENS|Rentabilitas operasi NeuroPace Inc (NPCE)|Tactile Systems Technology Inc. (TCMD) - Tingkat bathi adhedhasar bathi operasi|SANUWAVE Health Inc - Margin dodolan operasi|OM (outsetmedical.com) - Margin bathi operasi|SmartVest - Margin operasi|Rentabilitas kegiatan operasi LENSAR Inc. LNSR|AVITA Medical (RCEL) - Rentabilitas operasi|Margin bathi operasi PROF (Profound Medical Corporation)|Rentabilitas operasi bairdmed.com|Margin dodolan operasi EDAP TMS S.A. (EDAP)|Margin operasi APYX|ICCM - Rentabilitas dodolan operasi|Rentabilitas operasi pulmonx.com LUNG|TELA: Rentabilitas dodolan miturut bathi operasi|SRTS: Margin dodolan operasi|Zynex - Rasio bathi operasi|ECOR: Margin operasi|RBOT (Vicarious Surgical Inc) - Rentabilitas operasi|Rentabilitas operasi Inspira Technologies|Margin operasi SeaStar Medical Holding Corp.|Margin operasi IRIX|Rasio bathi operasi INBS|Rentabilitas operasi Beyond Air XAIR|PFSA (Profusa, Inc.) - Margin bathi operasi|SSKN: Margin dodolan operasi|Rentabilitas dodolan operasi GlucoTrack|NAOV: Margin operasi|Venus Concept Inc. - Tingkat bathi operasi|NUWE (Nuwellis Inc) - Margin operasi|Rentabilitas dodolan miturut bathi operasi AEMD (Aethlon)|Margin dodolan operasi ASXC (Asensus Surgical Inc)|AVGR (Avinger, Inc) - Tingkat bathi operasi|Margin operasi BSGM (BioSig Technologies, Inc.)|CUTR: Rentabilitas dodolan miturut bathi operasi|Know Labs Inc - Margin operasi|Rentabilitas kegiatan operasi Inari Medical NARI|NVRO (Nevro Medical) - Margin dodolan operasi|Margin bathi operasi RSLS (ReShape Lifesciences, Inc.)|SILK (Silk Road Medical, Inc.) - Margin operasi